Pharmaceutical industry and payer partnerships to manage costs and improve quality
Mauch, R.P.
Managed Care 10(9 Suppl) 2-4; Discussion: 9-12
2001
ISSN/ISBN: 1062-3388 PMID: 11729438 Document Number: 526940
Document emailed within 1 workday
Related Documents
Dunn, J.D.; Ellis, P.G.; Fox, J.L.; Klein, I.; Lopes, M.; Nash, D.B.; Nishida, L.; Schwartzberg, L.S.; Wong, W. 2010: Payer and provider collaborations that improve quality outcomes in oncology Managed Care 19(11): 35-40; 42Espedal, T. 1992: How can we improve hospital quality? can hospitals learn anything from industry? Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 112(14): 1877-1880
Robinson, D.S. 1994: Psychotropic drug labeling: regulatory, pharmaceutical industry, and clinical issues and perspectives. a pharmaceutical industry perspective on drug labeling Psychopharmacology Bulletin 30(1): 23-25
Tieman, J. 2003: Marching orders. Tricare restructuring, rebidding designed to cut costs, improve quality Modern Healthcare 33(20): 52 54
Jessee, W. 2003: Time for a change. Current payer systems must be overhauled to reduce complexity, costs Modern Healthcare 33(41): 26
Bell, C.W. 1991: We'd manage to care more if industry changed its name Modern Healthcare 21(40): 34
Conklin, M.S. 1994: Successful networks will manage indirect health costs for employers Health Care Strategic Management 12(6): 15
Schiff, G.D.; Bindman, A.B.; Brennan, T.A. 1994: A better-quality alternative. Single-payer national health system reform. Physicians for a National Health Program Quality of Care Working Group JAMA 272(10): 803-808
Miles, K.; Conlon, M.; Stinshoff, J.; Hutton, R. 2014: Public-private partnerships in the response to HIV: experience from the resource industry in Papua new Guinea Rural and Remote Health 14(3): 2868
Andersen, K. 1975: The responsibility of the pharmaceutical industry Nordisk Medicin 90(4): 115
Cohen, A.F. 2005: The pharmaceutical industry in uproar Nederlands Tijdschrift Voor Geneeskunde 149(19): 1074
Aumonier, J. 2003: Action of the pharmaceutical industry Annales Pharmaceutiques Francaises 61(6): 378-382
Schwarting, J.S. 2000: The pharmaceutical industry--to whom is it accountable? New England Journal of Medicine 343(19): 1416; Discussion 1417
Kahn, M.F. 1984: More on rheumatology and the pharmaceutical industry Journal of Rheumatology 11(5): 717-718
Walker, A.M.; García Rodríguez, L.A.; Pérez Gutthann, S. 1992: Epidemiology and the pharmaceutical industry Medicina Clinica 98(12): 465-468
Albers-Schönberg, G. 2002: Global trends in the pharmaceutical industry Puerto Rico Health Sciences Journal 21(2): 85-89
McKinney, W.P.; Rich, E.C. 2000: Gifts to physicians from the pharmaceutical industry JAMA 283(20): 2656-7; author reply 2657-8
De Francisco, A.L.M. 2004: Medical doctors and pharmaceutical industry Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 24(5): 393-394
Edwards, D.A. 2000: Gifts to physicians from the pharmaceutical industry JAMA 283(20): 2656; Author Reply 2657-8
Gray, C. 1981: The pharmaceutical industry: promoting research in the '80s Canadian Medical Association Journal 124(6): 787-792 Contd